PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8810782

[Body surface mapping].

H Hayashi
View original source ↗Export metadata ↓

Abstract

The body-surface map provides an integral picture containing more information on the activation sequence of the heart than is available from a standard 12-lead electrocardiogram (ECG) or vectorcardiogram (VCG), because the body-surface map has a larger number of lead points that the ECG, and they are uniformly distributed over the entire thorax and back. It supplies instant-by-instant information about the distribution of the positive and negative potential areas over the body surface. Therefore, body-surface mapping is a very powerful diagnostic tool for assessing the activation sequence of the heart and is likely to play an important role in determining the focus of various arrhythmias and the site of bypass tract and also clarifying the physiological mechanism of arrhythmias.

Explore related subjects

Arrhythmias, CardiacBody Surface Potential MappingHumansEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Hayashi. 1996. [Body surface mapping].. https://pubmed.ncbi.nlm.nih.gov/8810782/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.

The congenital long-QT syndrome (LQT3) and the Brugada syndrome are distinct, life-threatening rhythm disorders linked to autosomal dominant mutations in SCN5A, the gene encoding the human cardiac Na(+) channel. It is believed that these two syndromes result from opposite molecular effects: LQT3 mutations induce a gain of function, whereas Brugada syndrome mutations reduce Na(+) channel function. Paradoxically, an inherited C-terminal SCN5A mutation causes affected individuals to manifest electrocardiographic features of both syndromes: QT-interval prolongation (LQT3) at slow heart rates and distinctive ST-segment elevations (Brugada syndrome) with exercise. In the present study, we show that the insertion of the amino acid 1795insD has opposite effects on two distinct kinetic components of Na(+) channel gating (fast and slow inactivation) that render unique, simultaneous effects on cardiac excitability. The mutation disrupts fast inactivation, causing sustained Na(+) current throughout the action potential plateau and prolonging cardiac repolarization at slow heart rates. At the same time, 1795insD augments slow inactivation, delaying recovery of Na(+) channel availability between stimuli and reducing the Na(+) current at rapid heart rates. Our findings reveal a novel molecular mechanism for the Brugada syndrome and identify a new dual mechanism whereby single SCN5A mutations may evoke multiple cardiac arrhythmia syndromes by influencing diverse components of Na(+) channel gating function. The full text of this article is available at http://www.circresaha.org.

Arrhythmias, Cardiac↗